Home News Adherence to GMP Guidelines Critical for Gene Therapy Adherence to GMP Guidelines Critical for Gene Therapy March 1, 2005 March 1, 2005 (Vol. 25, No. 5) Informed Project Management Is Necessary to Guide the Process NewsBiological therapyBiomedical researchGene therapy (Therapeutics)Good manufacturing practiceMedicine, Diagnosis, and TherapeuticsQuality controlResearch and developmentTherapeutics Also of Interest REGENXBIO and AbbVie Advance Wet AMD Gene Therapy to Phase III Monoclonal Antibodies Are Paving the Way for Advanced Therapies New FDA Guidance Impacts the CAR-T Industry 10-Plus Days of High-Titer LV Generation Robots and AI: The Future of Cell and Gene Therapy Manufacturing HIV-Free Hopes Raised by Reservoir-Targeting VLPs Related Media Sickle Cell Salvation: The Victoria Gray Interview Bioprocessing in Beantown: GEN Reports Live from Day 2 at BPI Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning Excitement in Oakland: A Report from SynBioBeta Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Celebrating DNA: Matthew Cobb's Reflections on the Double Helix Related Content REGENXBIO and AbbVie Advance Wet AMD Gene Therapy to Phase III Monoclonal Antibodies Are Paving the Way for Advanced Therapies New FDA Guidance Impacts the CAR-T Industry 10-Plus Days of High-Titer LV Generation